TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate Academic Article uri icon

Overview

MeSH Major

  • Androstadienes
  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Enzyme Inhibitors
  • Neoplastic Cells, Circulating
  • Oncogene Proteins, Fusion
  • Orchiectomy
  • Prostatic Neoplasms
  • Steroid 17-alpha-Hydroxylase

abstract

  • ClinicalTrials.gov: NCT00474383 (COU-AA-003), NCT00485303 (COU-AA-004).

publication date

  • November 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3185163

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2011.07.011

PubMed ID

  • 21802835

Additional Document Info

start page

  • 897

end page

  • 904

volume

  • 60

number

  • 5